WSU Researchers Seek Subjects for Type 2 Diabetes Study

SPOKANE, Wash. — Researchers at WSU Spokane are seeking people with Type 2 diabetes to participate in an international study intended to produce new treatments for the disease.

In particular, the WSU researchers are looking for individuals with diabetes who have experienced some of the complications of the illness, such as high blood pressure and high cholesterol.

The Spokane research project is part of the Action to Control Cardiovascular Risk in Diabetes trial study being conducted under the direction of the National Institutes of Health in Bethesda, Md. Spokane is one of 70 sites across the United States and Canada participating in the research effort.

Once enrolled in the study, subjects will receive medications and close monitoring of their illness over the next few years. They will have to report every few weeks for a medical checkup by health care professionals working on the national study at WSU Spokane.

The Spokane researchers have enrolled 90 subjects in the study and want to enroll 150 before next summer. Their near-term goal is to increase the number of subjects in the study to 100 by the end of this year.

Information gained from the research will be used to help design future treatments for diabetes, according to Debbie Weeks, nurse and research coordinator.

For more information about participating, contact Weeks at (509) 358-7733, dweeks@wsu.edu, or Linda Kunstmann at (509) 358-7741, kunstman@wsu.edu.

• WSU Today article on ACCORD trial (Oct. 17, 2003): https://www.wsutoday.wsu.edu/completestory.asp?StoryID=759
• ACCORD trial central Web site: www.accordtrial.org